BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O’meara M, Cicalese MP, Bordugo A, Ambrosi A, Hadzic N, Mieli-vergani G. Successful Use of Long-Acting Octreotide for Intractable Chronic Gastrointestinal Bleeding in Children. Journal of Pediatric Gastroenterology & Nutrition 2015;60:48-53. [DOI: 10.1097/mpg.0000000000000540] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Cui PJ, Yao J, Zhu Y, Zhang ZY, Yang J. Effects of a Long-Acting Formulation of Octreotide on Patients with Portal Hypertension. Gastroenterol Res Pract 2017;2017:3943210. [PMID: 28855918 DOI: 10.1155/2017/3943210] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Mas E, Borrelli O, Broekaert I, de-Carpi JM, Dolinsek J, Miele E, Pienar C, Koninckx CR, Thomassen RA, Thomson M, Tzivinikos C, Benninga MA. Drugs in Focus: Octreotide Use in Children With Gastrointestinal Disorders. J Pediatr Gastroenterol Nutr 2022;74:1-6. [PMID: 34508049 DOI: 10.1097/MPG.0000000000003294] [Reference Citation Analysis]